Double-Dose Adenovirus-Mediated Adjuvant Gene Therapy Improves Liver Transplantation Outcomes in Patients with Advanced Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Double-Dose Adenovirus-Mediated Adjuvant Gene Therapy Improves Liver Transplantation Outcomes in Patients with Advanced Hepatocellular Carcinoma

Published:2018-02 Issue:2 Volume:29 Page:251-258
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Zhu Ruidong¹,Weng Danhui²,Lu Shichun¹,Lin Dongdong¹,Wang Menglong¹,Chen Dongdong¹,Lv Jun¹,Li Hongjun¹,Lv Fudong¹,Xi Ling²,Zhou Jianfeng²,Ma Ding²,Li Ning¹

Affiliation:

1. Beijing YouAn Hospital affiliated with Capital Medical University, Beijing, P.R. China.

2. Tumor Molecular Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P.R. China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2017.114

Reference31 articles.

1. Evolution of liver transplantation for hepatocellular carcinoma

2. Liver Cancer Working Group Report

3. The incidences and mortalities of major cancers in China, 2009

4. Liver transplantation for hepatocellular carcinoma

5. Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy for people with hepatocellular carcinoma;Cochrane Database of Systematic Reviews;2024-06-04

2. Clinical Efficacy and Safety of AdV-tk Gene Therapy for Patients with Cervical Squamous Intraepithelial Lesion: A Prospective Study;Human Gene Therapy;2023-10-01

3. Adenovirus as a Vector and Oncolytic Virus;Current Issues in Molecular Biology;2023-06-02

4. Donor graft METTL3 gene transfer ameliorates rat liver transplantation ischemia-reperfusion injury by enhancing HO-1 expression in an m6A-dependent manner;Clinical Immunology;2023-06

5. Role of Adenoviruses in Cancer Therapy;Frontiers in Oncology;2022-06-09